25 August 2016 A study published today in the New England Journal of Medicine reports on the 5 year results of the MINDACT (Microarray In Node-negative and 1 to 3 positive lymph node Disease may Avoid ChemoTherapy) trial. This study was designed to evaluate the use of a tumor gene signature test (MammaPrint) compared with […]

23 August 2016 A study published in the Annals of Internal Medicine evaluated screening mammography taking into account breast density and breast cancer risk. For women age 50-74, the conclusion of the authors was that for women of average risk with low breast density (fatty or scattered fibroglandular), triennial (every 3 year) mammography screening averted the […]

15 August 2016 A consensus statement was released today by the Society of Surgical Oncology, the American Society for Radiation Oncology, and the American Society of Clinical Oncology. It addresses the issue of surgical margins for patients undergoing breast conserving surgery (lumpectomy) for ductal carcinoma in-situ (DCIS). The summary notes “Use of a 2-mm margin as […]

An Oklahoma mayor underwent a 3D mammogram (tomosynthesis) as part of a hospital promotion. She was diagnosed with ductal carcinoma in-situ (DCIS, also known as Stage 0 breast cancer) and she stated that the study “…saved my life.” She also recommended that women make sure to obtain a 3D mammogram. The story noted that tomosynthesis […]

1 August 2016 A study published in JAMA Oncology demonstrated that women who were engaged in social media after being diagnosed with breast cancer were more likely to express positive feelings and satisfaction related to their treatment decisions. The authors surveyed 2460 newly diagnosed breast cancer patients about their social media use including texting, email, […]

1 August 2016 ***NOTE: Dr. Attai does not currently have cryoablation equipment.  Some patients with benign breast fibroadenomas are candidates for a non-surgical therapy called cryoablation. The procedure involves freezing the benign lump within the breast, and the mass reabsorbs without the need for surgical removal. The in-office procedure is performed under local anesthesia, and usually […]

During the April 2016 meeting of the American Society of Breast Surgeons (ASBrS), a consensus conference was held to discuss contralateral prophylactic mastectomy (CPM). CPM is the removal of the healthy, opposite breast, and the rates of CPM have been increasing, for various reasons. A patient’s decision to undergo a CPM is very difficult and is unique to […]